Revenue (Tables)

12 Months Ended

Sep. 30, 2020

Revenue From Contract With Customer [Abstract]

Summary of Revenues Disaggregated by Product Classification and Reportable Segment

The following table presents the Company’s revenues disaggregated by product classification and by reportable segment:

	Fiscal Year
(In thousands)	2020		2019		2018
Medical Device
Product sales	$	21,608	$	18,617	$	17,200
Royalties		28,614		34,781		30,606
License fees		12,020		13,678		4,818
Research, development and other		9,159		11,277		7,889
Total Revenue — Medical Device		71,401		78,353		60,513
In Vitro Diagnostics
Product sales		22,709		21,390		20,789
Other		754		334		34
Total Revenue — In Vitro Diagnostics		23,463		21,724		20,823
Total Revenue	$	94,864	$	100,077	$	81,336